Cervical Cancer and Lymph Nodes: Spread, Staging, and Treatment

Lymph nodes are often the first place cervical cancer reaches beyond the cervix, and whether they are involved is one of the biggest factors shaping a woman’s stage and treatment. Since 2018, cancer found in the nodes puts a cervical cancer in stage III no matter how small the tumour in the cervix is.¹

How Cervical Cancer Travels Through the Lymph Nodes

Lymph nodes are bean-sized filters spaced along the body’s fluid channels. They trap germs and, sometimes, cancer cells. The cervix drains first into the pelvic nodes, and cervical cancer most often follows that route: first the nodes along the pelvic blood vessels, then nodes near where those vessels join, then the para-aortic nodes, which sit higher in the belly along the aorta.² In women with larger tumours, almost no one had cancer in the nodes near where the vessels join without the lower pelvic nodes also being affected.³

The pattern isn’t absolute. Cancer skips straight to the para-aortic nodes in roughly 3 to 6 of every 100 women.⁴ That is why doctors still check the higher nodes rather than relying on the pattern alone.

Your report may list node groups by name: obturator, external iliac, internal iliac, common iliac, presacral and para-aortic. The first three sit low in the pelvis beside the major blood vessels. Common iliac and presacral nodes sit a little higher, near the lower back. Para-aortic nodes run up alongside the aorta, behind the abdomen. It is worth asking your team which groups are involved and on which side.

“Node-positive” doesn’t mean the cancer is everywhere. Pelvic and para-aortic nodes count as regional disease, meaning the cancer is still within the area that drains the cervix, not in a faraway organ. Cancer in distant places such as the lungs or liver is a separate finding, called stage IVB, and doctors look for it with whole-body scans.

How Lymph Nodes Change Your Stage

Cervical cancer is staged with the FIGO system, which was revised in 2018 to use modern scans and surgery results.⁵ Under it, cancer in pelvic nodes is stage IIIC1 and cancer in para-aortic nodes is stage IIIC2.⁶ Nodes count whether they are found on a scan or confirmed under a microscope after surgery.⁷ The change was made because older staging relied on a physical exam, which misjudged the stage in 20 to 40 of every 100 women with stage IB to IIIB cancer.⁸

The stage now reflects how far the cancer has spread as well as how big the tumour is, so a small tumour with node involvement is no longer classed as early. A 2 cm tumour with one positive pelvic node, for example, is stage IIIC1. Your report may add a small “r” (found on imaging) or “p” (confirmed by pathology after surgery) after the stage, showing how the nodes were judged. Stage IIIC is a different situation from stage IIIA or IIIB, which are based on how the tumour has grown locally, and the outlook differs, so ask which one you have.

How Scans Look for Cancer in the Nodes

In women with early-stage cervical cancer, PET-CT picked up about 80 of every 100 women with node spread, MRI about 48 and CT about 40.⁹ PET-CT also flagged more nodes that turned out to be clear: about 21 in 100 women without spread were wrongly flagged, versus 8 for MRI and CT.¹⁰ Inflamed nodes can light up or swell just like cancerous ones, and normal-sized nodes can still hold cancer.¹¹ An MRI setting that tracks how water moves in tissue catches about 86 in 100 affected pelvic nodes.¹²

Every scan has a limit. Deposits under about 5 mm are hard for PET-CT to see.¹³ Among women whose pelvic nodes were positive but whose higher nodes looked clear on PET-CT, about 21 in 100 still had hidden para-aortic cancer.¹⁴

On a report, “suspicious node” means a node has a size, shape or level of activity that could fit cancer, not that cancer has been proven. Doctors may still plan treatment as if the node is positive, especially when several features point the same way. Ask whether a biopsy or surgery is planned to confirm it, because confirmation can change how treatment is aimed.

MRI is common for looking at the tumour and the pelvis. PET-CT is often added for larger tumours, to check the nodes and look for distant spread. None of these scans hurts, though PET needs a sugar tracer injection and fasting beforehand.

Sentinel Node Biopsy and Node Removal Surgery

The sentinel lymph node is the first node the cervix drains into. Surgeons find it by injecting a tracer into the cervix during surgery. A green fluorescent dye finds a sentinel node on both sides of the pelvis in about 90 of every 100 women, compared with about 74 using a radioactive tracer with blue dye.¹⁵ Finding nodes on both sides matters because each side drains separately.¹⁶

About 12 to 13 of every 100 women with early-stage cancer had cancer in a sentinel node.¹⁷ The quick check during surgery found only about 57 of every 100 of these, and slicing the node finely afterward found the rest.¹⁸

Removing all the pelvic nodes leads to fluid pockets in about 35 of every 100 women and leg swelling in about 11.¹⁹ In a small study, women who skipped full removal after a clear sentinel node had much less leg swelling and no node recurrences.²⁰

If a node is found to be positive during surgery, surgeons may stop the hysterectomy rather than continue. This avoids stacking major surgery on top of radiation, which raises side effects. Treatment then usually switches to chemoradiation.

Before surgery, ask whether sentinel node mapping will be used and with which tracer, since the dye choice affects how often nodes are found. Ask what happens if a sentinel node isn’t found on one side, as surgeons often then remove the nodes on that side. Ask whether full node removal will be done only if needed, and when final results from detailed testing will come back, since they can take days to a couple of weeks.

Treatment When Lymph Nodes Are Involved

Women with positive nodes are usually treated with chemoradiation: radiation given alongside chemotherapy that makes it work better. Modern radiation can give a higher dose to the affected nodes in the same sessions, usually without severe bowel or bladder harm.²¹ In one group treated this way, no cancer remained or returned in the boosted nodes, and about 71 in 100 were alive at 3 years.²²

A course usually runs on weekdays over about five to six weeks, with each visit taking a short time. Chemotherapy is often given once a week alongside it. Internal radiation to the cervix, called brachytherapy, usually follows the external course. Tiredness, diarrhoea and bladder irritation are common during treatment, and your team can help manage them.

Standard pelvic radiation doesn’t reach the para-aortic nodes.²³ If those nodes are involved, doctors extend the field upward, called extended-field radiation.²⁴ About half of women treated this way had a serious drop in blood counts, though serious bowel or bladder effects were rare.²⁵ Adding upward radiation as a precaution when only pelvic nodes were positive didn’t improve 10-year survival in one study.²⁶

For higher-risk locally advanced cancer, including node-positive stage III, adding the immune drug pembrolizumab to chemoradiation kept the cancer from growing at 2 years in 68 of every 100 women, versus 57 without it.²⁷ For cancer that has spread widely or come back, the same drug raised 2-year survival from about 42 to 53 in every 100.²⁸

Eligibility for immunotherapy depends on stage and node status, so ask whether your stage qualifies and whether it’s available where you’re treated. It is given by drip and continues after radiation ends. Immune side effects such as thyroid changes need monitoring.

Outlook With Positive Lymph Nodes

The number of affected pelvic nodes is one of the strongest predictors of outcome.²⁹ When cancer grows through a node’s outer wall, called extracapsular spread, the 5-year survival in one group was about 34 in 100 versus 61 without it.³⁰ Another analysis found it raised the chance of recurrence more clearly than it lowered survival.³¹ Women with node spread have a higher recurrence rate and need close follow-up.³²

Survival figures come from women treated years ago, before some newer options were available. They describe groups of women, not what will happen to any one person. Your team can give a more personal estimate based on your nodes, stage and response to treatment. Ask whether your report mentions spread through the node’s outer wall, since it is one of the features that matters.

Follow-up usually means visits every few months for the first two to three years, with exams and scans if symptoms arise. Report new pain, swelling, bleeding or weight loss promptly.

Leg Swelling and Other Side Effects From Node Treatment

Lymphedema is lasting swelling, usually in the legs, that happens when lymph can’t drain properly after nodes are removed or radiated. It affected about 13 in 100 women after surgery for early cancer, and radiation after surgery raised the risk about threefold.³³ About 4 in 5 cases appeared within 3 years of treatment.³⁴ Risk rises with more nodes removed, infection, older age, higher weight and low activity.³⁵

Sentinel node surgery instead of full removal lowers the risk. Surgeons can also reconnect lymph channels during node removal, which reduced swelling in early studies, though data for the legs are limited.³⁶ Staying active, keeping a healthy weight and treating skin infections quickly all help lower your risk.

Heaviness or tightness in one leg, the groin or the genitals can come before visible swelling. Shoes or trousers may feel tighter on one side. Early on, swelling may be worse at the end of the day and ease overnight. Red, hot, painful skin may mean infection and needs prompt medical care.

Treatment usually starts with a referral to a lymphedema therapist, who uses gentle massage to drain the fluid. Fitted compression stockings are worn daily, alongside exercise and skin care routines. Starting early can help keep swelling from becoming permanent.